Increased Cefazolin During Cesarean Delivery in Obese Population

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
ObesityObesity, MorbidPregnancyInfection; Cesarean Section
Interventions
DRUG

Cefazolin

Participants who are undergoing an elective cesarean section at term will receive 3 grams of Cefazolin at least 30, but no more than 60 minutes prior to skin incision administered through an intravenous line.

Trial Locations (2)

90806

MemorialCare Center for Women at Miller Children's Hospital Long Beach and Long Beach Memorial Medical Center, Long Beach

92868

University of California, Irvine, Orange

All Listed Sponsors
collaborator

University of California, Irvine

OTHER

lead

MemorialCare Health System

OTHER

NCT02049944 - Increased Cefazolin During Cesarean Delivery in Obese Population | Biotech Hunter | Biotech Hunter